Annual Accounts Payable
N/A
December 31, 2023
Summary
- MNPR annual accounts payable is not available.
Performance
MNPR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
N/A
September 30, 2024
Summary
- MNPR quarterly accounts payable is not available.
Performance
MNPR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MNPR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MNPR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Monopar Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.98 M(-20.8%) |
| Jun 2023 | - | $2.50 M(-13.4%) |
| Mar 2023 | - | $2.89 M(-7.7%) |
| Dec 2022 | $3.13 M(+98.0%) | $3.13 M(+63.4%) |
| Sep 2022 | - | $1.91 M(-12.5%) |
| Jun 2022 | - | $2.19 M(+103.6%) |
| Mar 2022 | - | $1.07 M(-32.0%) |
| Dec 2021 | $1.58 M(+34.3%) | $1.58 M(+27.5%) |
| Sep 2021 | - | $1.24 M(+12.4%) |
| Jun 2021 | - | $1.10 M(+36.9%) |
| Mar 2021 | - | $806.30 K(-31.5%) |
| Dec 2020 | $1.18 M | $1.18 M(+117.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $542.10 K(+3.1%) |
| Jun 2020 | - | $525.70 K(+18.5%) |
| Mar 2020 | - | $443.50 K(-38.8%) |
| Dec 2019 | $724.20 K(+81.2%) | $724.20 K(+49.7%) |
| Sep 2019 | - | $483.70 K(+3.3%) |
| Jun 2019 | - | $468.30 K(-19.3%) |
| Mar 2019 | - | $580.00 K(+45.1%) |
| Dec 2018 | $399.60 K(+28.1%) | $399.60 K(+28.1%) |
| Sep 2018 | - | $311.90 K(-3.5%) |
| Jun 2018 | - | $323.10 K(+11.2%) |
| Mar 2018 | - | $290.60 K(-6.8%) |
| Dec 2017 | $311.90 K(+383.6%) | $311.90 K |
| Dec 2016 | $64.50 K | - |
FAQ
- What is the all time high annual accounts payable for Monopar Therapeutics?
- What is the all time high quarterly accounts payable for Monopar Therapeutics?
What is the all time high annual accounts payable for Monopar Therapeutics?
Monopar Therapeutics all-time high annual accounts payable is $3.13 M
What is the all time high quarterly accounts payable for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly accounts payable is $3.13 M